Biolab Pharma

Brazil - São PauloPharmaceutical2 H-1B visas (FY2023)

Focus: Biolab Pharma is a Brazil-based pharmaceutical company focused on small molecule development across oncology and gastroenterology. The company operates at modest scale with a diverse, early-to-mid stage pipeline.

Oncology Gastroenterology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Biolab Pharma

AI assessmentNot Hiring

No open roles listed right now. Follow Biolab Pharma to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthStrong

Pipeline

Late-stage

9 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

IP1: BioLab Membrane Wrap Lite IP2: BioLab Tri-Membrane Wrap

Diabetic Foot Ulcer (DFU)

N/A

Clinical Trials (1)

NCT07046767CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations

N/A

Help build intelligence for Biolab Pharma

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Active clinical development across 20 programs with multiple Phase 3 candidates (5 programs) offering hands-on involvement in trial-critical roles
Geographic diversification as a São Paulo-based company provides alternative pharma ecosystem exposure and potential visa sponsorship (2 H1B approvals in 2023, zero denials)
Focused therapeutic areas (oncology, gastroenterology) create specialized expertise development opportunities in high-value disease segments

Watch Out For

No active job openings currently listed; hiring appears stalled or dormant, limiting near-term employment prospects
Sparse data on financials, revenue, R&D intensity, and company stage creates visibility risk—pre-revenue or early-stage status cannot be confirmed but is suggested by pipeline-only profile

Generated by Claude from Biolab Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Tri-Membrane Wrap™

Venous Leg Ulcer (VLU)

N/A

Clinical Trials (1)

NCT07078968A REAL WORLD DATA COLLECTION OF HUMAN AMNIOTIC MEMBRANE(S) ON DIABETIC FOOT ULCERS, VENOUS LEG ULCERS, PRESSURE ULCERS AND POST OPERATIVE WOUNDS

N/A

Membrane Wrap™

Venous Leg Ulcer

N/A

Clinical Trials (1)

NCT06544564Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population

N/A

Stryphnodendron Adstringens 3% - once daily post bath

Vaginal Flora Imbalance

N/A

Clinical Trials (1)

NCT06085898Stryphnodendron Adstringens Intimate Soap

N/A

postbiotics

Geographic Atrophy

N/A

Clinical Trials (1)

NCT05391074Oral Postbiotics in Patients With Macular Atrophy

N/A

Postbotics and Vitamins

AMD

N/A

Clinical Trials (1)

NCT05056025Study to Evaluate the Response to Supplementation With Postbiotics in Patients With Macular Degeneration.

N/A

IGEN0206

Quality of Life of Patients

N/A

Clinical Trials (1)

NCT04009122Evaluation of the Quality of Life of Patients With Metastatic Non-small Cell Lung Cancer With Supplementary Therapy With IGEN-0206

N/A

Eplerenone 25 mg

Healthy Volunteers

Phase 1

Clinical Trials (1)

NCT02607657Pharmacokinetics of Eplerenone Tablet

Phase 1

Zolpidem Hemitartarate

Healthy Volunteers

Phase 1

Clinical Trials (1)

NCT02607696Pharmacokinetics of Zolpidem Orodispersible Tablet

Phase 1

zolpidem hemitartarate tablet 3.5 mg

Healthy

Phase 1

Clinical Trials (1)

NCT02817750Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation

Phase 1

Rebamipide effervescent granules

Gastrointestinal Lesions

Phase 1

Clinical Trials (1)

NCT02632812Gastrointestinal Integrity After Naproxen + Rebamipide Versus Naproxen + Placebo

Phase 1

Test formulation

Contraception

Phase 1

Clinical Trials (1)

NCT03443089Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate

Phase 1

eplerenone

Pharmacokinetics

Phase 1

Clinical Trials (1)

NCT02957435Pharmacokinetics Study of Eplerenone Coated Tablets

Phase 1

Isosorbide Mononitrate

Anal Fissure

Phase 1

Clinical Trials (1)

NCT02667535PK, PD and Safety Comparative Trial of Isosorbide Mononitrate Gel in Healthy Participants and With Anal Fissure

Phase 1

Isosorbide mononitrate

Pharmacokinetics

Phase 1

Clinical Trials (1)

NCT04729088Pharmacokinetics Trial of Isosorbide Mononitrate 0.5% Gel for Intra Anal Application in Healthy Subjects

Phase 1

Lidocaine + Prilocaine

Topical Anesthesia

Phase 1

Clinical Trials (1)

NCT03441841Pharmacokinetic Study of Nanoencapsulated Gel of Lidocaine, Prilocaine and Combination of Lidocaine and Prilocaine

Phase 1

zolpidem hemitartarate 1.75 mg - Sequency 1

Healthy

Phase 1

Clinical Trials (1)

NCT02814058Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 1.75 mg Formulation

Phase 1

Testosterone gel 1% 2.2 mg

Post-menopausal Period

Phase 1

Clinical Trials (1)

NCT02667561Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%

Phase 1

TB511

NSCLC

Phase 1/2

Clinical Trials (1)

NCT06400160Clinical Trial of TB511 in Advanced Solid Tumors

Phase 1/2

Dapaconazole

Tinea Cruris

Phase 2

Clinical Trials (1)

NCT03359070Clinical Trial Comparing Dapaconazole Versus Miconazole in Patients With Tinea Cruris

Phase 2

Dapaconazole

Tinea Pedis

Phase 2

Clinical Trials (1)

NCT02824926Clinical Trial Comparing BL123 Versus Ketoconazole in Patients With Tinea Pedis

Phase 2

CBLB502

Colorectal Cancer

Phase 2

Clinical Trials (1)

NCT02715882Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer

Phase 2

CBLB612

Breast Cancer

Phase 2

Clinical Trials (1)

NCT02778763Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis

Phase 2

Zolpidem

Insomnia Disorder

Phase 2/3

Clinical Trials (1)

NCT03885141Biolab Zolpidem Orodispersible 1.0 mg, 1.75 mg and 3.5 mg to Treat Maintenance Insomnia Disorder.

Phase 2/3

Dapaconazole

Tinea Pedis

Phase 3

Clinical Trials (1)

NCT03320486Non-inferiority Trial of Dapaconazole Versus Ketoconazole

Phase 3

Botulinum Toxin A

Skin Aging

Phase 3

Clinical Trials (1)

NCT00986570Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face

Phase 3

L-carnitine and piracetam

Postpoliomyelitis Syndrome

Phase 3

Clinical Trials (1)

NCT01549847A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome

Phase 3

0.20% sodium hyaluronate gel

Vaginismus

Phase 3

Clinical Trials (1)

NCT06564883Hydration and Acceptability of the Genital and Skin Mucosa of a Vaginal Moisturizer in Menopausal Women

Phase 3

550 mg naproxen + 300 mg rebamipide + 20 mg rabeprazole.

Gastric Lesion

Phase 3

Clinical Trials (1)

NCT03658473Evaluation of Rebamipide and Rabeprazole Effect Associated or Not to Prevent Naproxen-induced Gastric Lesions

Phase 3

ethinyl estradiol + levonorgestrel + folic acid

Contraception

Phase 3

Clinical Trials (1)

NCT03359057Trial Evaluating Folic Acid Supplementation by Concomitant Administration of Ethinyl Estradiol + Levonorgestrel

Phase 3

Dapaconazole

Tinea Pedis

Phase 3

Clinical Trials (1)

NCT02606383Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis

Phase 3

BL 3000

Telogen Effluvium

Phase 3

Clinical Trials (1)

NCT04880889BL3000 Compared to Pantogar® in the Treatment of Telogen Effluvium in Women.

Phase 3

Lidocaine / Prilocaine Cream

Lidocaine Adverse Reaction

Phase 3

Clinical Trials (1)

NCT03366246Efficacy of a Topical Anesthetic Containing Lidocaine and Prilocaine in Treatment With CO2 Fractional Laser

Phase 3

Standard of Care DFU

Diabetic Foot

Phase 4

Clinical Trials (1)

NCT07089602Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers

Phase 4

Tri-Membrane Wrap™ DFU

Diabetic Foot Ulcer

Phase 4

Clinical Trials (1)

NCT07364630A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.

Phase 4